Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rene Welch

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Biorxiv : the Preprint Server for Biology|May 7, 2026
A Head and Neck Cancer Patient-Specific Microphysiological System for Predicting Response to ChemoradiationAdeel Ahmed, Nathan Hendrikse, Rene Welch Schwartz, et al.
Mbio|August 22, 2019
Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell CycleMark R Eichelberg, Rene Welch, J Tod Guidry, et al.
Melanoma Research|May 20, 2024
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanomaMark R Albertini, Cindy L Zuleger, Erik A Ranheim, et al.
Cancer Immunology Research|July 8, 2026
In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer modelsTrishna Debnath, Won Jong Jin, Ravi B Patel, et al.
Cancer Research|March 26, 2026
Integrated Multi-omic Profiling Identifies BRD8/EP400 as a Pivotal Chromatin Module Mediating Anti-HER2 Response in HR+/HER2+ Breast CancerAng Gao, Parth H Khatri, Gui Ma, et al.
Human Mutation|February 22, 2017
Predicting gene expression in massively parallel reporter assays: A comparative studyAnat Kreimer, Haoyang Zeng, Matthew D Edwards, et al.
JCI Insight|April 1, 2025
Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinomaUsha S Polaki, Trey E Gilpin, Apoorva T Patil, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biorxiv : the Preprint Server for Biology|May 7, 2026
A Head and Neck Cancer Patient-Specific Microphysiological System for Predicting Response to ChemoradiationAdeel Ahmed, Nathan Hendrikse, Rene Welch Schwartz, et al.
Mbio|August 22, 2019
Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell CycleMark R Eichelberg, Rene Welch, J Tod Guidry, et al.
Melanoma Research|May 20, 2024
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanomaMark R Albertini, Cindy L Zuleger, Erik A Ranheim, et al.
Cancer Immunology Research|July 8, 2026
In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer modelsTrishna Debnath, Won Jong Jin, Ravi B Patel, et al.
Cancer Research|March 26, 2026
Integrated Multi-omic Profiling Identifies BRD8/EP400 as a Pivotal Chromatin Module Mediating Anti-HER2 Response in HR+/HER2+ Breast CancerAng Gao, Parth H Khatri, Gui Ma, et al.
Human Mutation|February 22, 2017
Predicting gene expression in massively parallel reporter assays: A comparative studyAnat Kreimer, Haoyang Zeng, Matthew D Edwards, et al.
JCI Insight|April 1, 2025
Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinomaUsha S Polaki, Trey E Gilpin, Apoorva T Patil, et al.
Pageof 2